OUTCOMES AFTER HEART TRANSPLANTATION FOR LIGHT-CHAIN COMPARED TO TRANSTHYRETIN AMYLOIDOSIS

Autor:	Jeffeny De Los Santos, Evelyn M. Horn, Susan Restaino, Sergio Teruya, Leonard Chiu, A. Reshad Garan, E. Lin, Maryjane Farr, Jennifer Haythe, Hiroo Takayama, Melana Yuzefpolskaya, Sun Hi Lee, Jeff Goldsmith, Koji Takeda, Paolo C. Colombo, Yoshifumi Naka, Stephen Helmke, Kelly Axsom, Farhana Latif, Mathew S. Maurer
Rok vydání:	2019
Předmět:	Heart transplantation medicine.medical_specialty biology business.industry medicine.medical_treatment Amyloidosis medicine.disease Immunoglobulin light chain Transthyretin Cardiac amyloidosis Internal medicine biology.protein Cardiology Medicine Cardiology and Cardiovascular Medicine business Attr amyloidosis
Zdroj:	Journal of the American College of Cardiology. 73:920
ISSN:	0735-1097
Popis:	Light-chain (AL) has a worse prognosis than transthyretin (ATTR) cardiac amyloidosis. We compare post-OHT survival for AL and ATTR amyloidosis, hypothesizing that AL would have worse outcomes. 39 patients with cardiac amyloidosis (AL, n = 18; ATTR, n = 21) and 1023 non-amyloidosis subjects
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::887077f368c6bda768505369f2e979d5 https://doi.org/10.1016/s0735-1097(19)31527-x Zobrazit plný text záznamu